
From lab to life: Driving the future of cancer science.
Join Revvity at the AACR Annual Meeting 2025 in Chicago. Our commitment to driving progress in cancer science from the lab to real-world impact has never been stronger.
Bringing together our expertise and passion, our team will showcase platforms and products covering:
- 3D cell analysis and AI
- BioLegend reagents
- Immunoassays
- In vivo imaging
- Genomic solutions
- Next-generation sequencing
Come and share your research with us in booth # 1200 and chat with our poster presenters.
Let us unite your science with our innovative solutions to transform the landscape of cancer research. One mission. Multiple solutions. Endless breakthroughs.
Not affiliated with or endorsed by AACR.
For research use only. Not for use in diagnostic procedures.

BOOTH # 1200
Revvity at AACR Annual Meeting 2025
Empower your cancer science in booth 1200!
We're eager to connect with you at our booth! Come share your innovative approaches to cancer research, and let's explore how our latest platforms, assays, and reagents can support your work and shape the future of cancer science.

3D cell analysis and AI
Facilitate breakthroughs with detailed cell analysis and AI-driven insights.
- NEW Phenologic.AI™ pre-trained deep-learning cell image-analysis module for Harmony™ and Signals Image Artist™ software
- Cell counters and image cytometers
- Cellular imaging reagents including cell painting kits
- Cellular imaging microplates
- High-content imaging instruments
- Cellular imaging and analysis software
- Revvity Signals Research Suite™ software platform
- Preclinical services


In vivo imaging solutions
Accelerate your drug development by tracking disease progression, evaluating efficacy, and assessing toxicity.


Genomic solutions
Decode cancer's blueprint at a molecular level through precision genomics.


Next-generation sequencing
Improve your productivity with complete library prep workflows.


Immunoassays
Monitor key phosphorylation events and detect biomarkers to advance your cancer research and therapeutic discovery with our extensive range of immunoassay technologies.


BioLegend
Advance your cancer research with reliable reagents for tumor phenotyping and development of novel immunotherapies.


What's new
Discover Revvity's latest innovations in AI and cellular imaging to streamline your workflow and open up new possibilities for understanding cellular behaviors and disease mechanisms.
- Harmony 5.3 cellular imaging software
- Phenologic.AI pre-trained deep-learning cell image-analysis module
Speed up in vivo imaging workflows with our new innovative technology to rapidly administer targeted delivery of cells and drug therapies into mice.
Explore our expanding portfolio of over 120 cell line-derived reference standards, now including a quantitative multiplex moderate FFPE control and FFPE panels for prostate, lymphoid, and colorectal cancer.
Explore BioLegend's latest reagent innovations to advance your cancer and immuno-oncology research.
- TotalSeq PhenoCyte provides high-throughput, high-parameter single-cell protein analysis.
- TotalSeq-A and -C Universal Cocktails, v2.0 offer expanded coverage of markers for translational research and immuno-oncology applications.
- LEGEND MAX™ High Sensitivity Mouse TNF-a and ELISA MAX™ Deluxe Set Human ICAM-1 kits can help understand the tumor microenvironment.
Discover Revvity's latest innovations in AI and cellular imaging to streamline your workflow and open up new possibilities for understanding cellular behaviors and disease mechanisms.
- Harmony 5.3 cellular imaging software
- Phenologic.AI pre-trained deep-learning cell image-analysis module
Speed up in vivo imaging workflows with our new innovative technology to rapidly administer targeted delivery of cells and drug therapies into mice.
Explore our expanding portfolio of over 120 cell line-derived reference standards, now including a quantitative multiplex moderate FFPE control and FFPE panels for prostate, lymphoid, and colorectal cancer.
Explore BioLegend's latest reagent innovations to advance your cancer and immuno-oncology research.
- TotalSeq PhenoCyte provides high-throughput, high-parameter single-cell protein analysis.
- TotalSeq-A and -C Universal Cocktails, v2.0 offer expanded coverage of markers for translational research and immuno-oncology applications.
- LEGEND MAX™ High Sensitivity Mouse TNF-a and ELISA MAX™ Deluxe Set Human ICAM-1 kits can help understand the tumor microenvironment.
Posters
Using the Celigo™ Image Cytometer for effectively screening rAAV gene delivery methods
When: Sunday Apr 27, 2025, 2:00 PM – 5:00 PM
Where: Poster Section 21
Session title: Gene and Vector-Based Therapy
Category: Experimental and Molecular Therapeutics
Poster board number: 19
Abstract presentation number: 485
Utilization of longitudinal ultrasound imaging as a novel pharmacodynamic marker of graft versus host disease progression in mice
When: Monday Apr 28, 2025, 2:00 PM – 5:00 PM
Where: Poster Section 1
Session title: Advanced Nanotechnology and Imaging
Category: Tumor Biology
Poster board number: 11
Abstract presentation number: 2532
High-throughput hybridoma monoclonality characterization using the Celigo™ Image Cytometer
When: Monday April 28, 2025, 2:00 PM - 5:00 PM
Where: Poster Section 25
Session title: High-Throughput Screening Assays and Libraries
Category: Chemistry
Poster board number: 21
Abstract presentation number: 3168
Cyclin-dependent kinase signaling in oncology: assessing the effectiveness of a CDK9-targeting using no-wash immunoassays
When: Tuesday Apr 29, 2025, 9:00 AM - 12:00 PM
Where: Poster Section 12
Session title: Kinases/Phosphatases, Ubiquitin, and Ubiquitin-like Proteins
Category: Molecular/Cellular Biology and Genetics
Poster board number: 8
Abstract presentation number: 4133
Rapid automatic segmentation of murine lung volumes from micro-CT images using deep learning to reduce analysis burden
When: Tuesday Apr 29, 2025, 2:00 PM – 5:00 PM
Where: Poster Section 46
Session title: New Software Tools and Machine Learning Methods
Category: Bioinformatics / Computational Biology / Systems Biology / Convergent Science
Poster board number: 29
Abstract presentation number: 6315
Development of a novel fluorescent ELISpot assay using the Celigo™ Image Cytometer
When: Tuesday April 29, 2025, 2:00 PM - 5:00 PM
Where: Poster Section 16
Session title: Drug Discovery Assay Technologies
Category: Experimental and Molecular Therapeutics
Poster board number: 1
Abstract presentation number: 5473
Performance characterization of the Cellometer Ascend automated cell counter following ISO cell counting standards
When: Tuesday April 29, 2025, 2:00 PM - 5:00 PM
Where: Poster Section 22
Session title: Novel Methods in Small Molecule and Biologics Drug Discovery
Category: Experimental and Molecular Therapeutics
Poster board number: 14
Abstract presentation number: 5669
Feasibility of automatic spleen volumetry from 3D ultrasound images of mice using deep learning
When: Wednesday Apr 30, 2025, 9:00 AM - 12:00 PM
Where: Poster Section 44
Session title: Artificial Intelligence and Machine/Deep Learning
Category: Bioinformatics / Computational Biology / Systems Biology / Convergent Science
Poster board number: 21
Abstract presentation number: 7443
Automated quantification of small animal liver tumor volume in longitudinal MR imaging using deep learning
When: Wednesday Apr 30, 2025, 9:00 AM - 12:00 PM
Where: Poster Section 44
Session title: Artificial Intelligence and Machine/Deep Learning
Category: Bioinformatics / Computational Biology / Systems Biology / Convergent Science
Poster board number: 22
Abstract presentation number: 7444
Unlocking cell cycle dynamics: Gene regulation of CRISPR-Cas9 and siRNA phenotypes using cell painting
When: Wednesday Apr 30, 2025, 9:00 AM - 12:00 PM
Where: Poster Section 53
Session title: Late-Breaking Research |
Category: Molecular/Cellular Biology and Genetics 3
Poster board number: 1
Abstract presentation number: LB443
Special AACR savings!
As a valued AACR Annual Meeting 2025 attendee, enjoy 10% OFF Revvity reagents, assay kits, and consumables - now through May 16. Shop at Revvity.com or through your Revvity punchout and use promo code AACR2025 at checkout.
Explore Revvity solutions in this special offer
TERMS AND CONDITIONS: For a limited time, attendees of the American Association for Cancer Research® (AACR) Annual Meeting held April 25-30, 2025 in Chicago, IL ("Event") will be eligible to receive a ten percent (10%) discount off the list price of select Revvity research reagents, consumables, and minor accessories using code AACR2025. This promotion is only open to attendees of the Event and when placing an order, the attendee must use promo code: AACR2025. Discount is valid on orders up to $25,000 USD. Orders over this amount will have the discount applied to the first $25,000 USD only. This offer is valid for customers in the United States, Canada, Australia and European customers in France, Germany, Spain, Italy, UK, Ireland, Sweden, Norway, Finland, Denmark, Belgium, The Netherlands, Luxembourg, Austria, and Switzerland purchasing via (1) Revvity.com, (2) requisitions initiated on the Revvity punchout (enter code in the shopping cart), and/or (3) automated e-procurement integration (cXML or EDI; reference AACR2025 in the order comments). The aforementioned methods of purchase are the only ways for the promotion to apply, as the promotion does not apply to any orders sent by email to Revvity Customer Care. Offer excludes instruments and major accessories and is only valid for direct B2B transactions (distributors are excluded). This promotion is available to businesses, institutions, and companies in countries where legally permissible. Discounts cannot be applied to existing, pending, or prior orders and may not be combined with any other discounts, offers, or promotions, including, but not limited to, other price discounts, volume purchase agreements, university programs, standing order discounts, or other contract pricing. Customer is responsible for all applicable charges, taxes, shipping, and other related expenses; no discount will be applied to such costs. This discount may be discontinued, suspended, or amended by Revvity in its sole discretion at any time without further notice in the United States, Canada, Australia, or any other country where legally permissible. No cash or cash equivalent; no substitutions. Revvity has sole discretion to determine eligibility and may require proof of eligibility. Offer valid from April 25, 2025, through May 16, 2025 (11:59pm EST). Offer void where prohibited, licensed, or restricted by applicable law or regulation. Other limitations and restrictions may apply. All information submitted to Revvity in connection with this promotion will be treated in accordance with Revvity’s privacy policy, available at website privacy notice.